StockWatch
·
Glass - Industrial
Board Meeting16 Jul 2026, 03:37 pm

Borosil Renewables swings to ₹86.6 Cr consolidated PAT; solar-glass margins hold at guided 31%

AI Summary

Borosil Renewables reported a clean turnaround in Q1 FY27 (quarter ended June 30, 2026), posting consolidated PAT of ₹86.6 Cr against a loss of ₹203.5 Cr a year ago, on revenue of ₹405.7 Cr, up 17.1% YoY. The prior-year loss was almost entirely a ₹222 Cr exceptional impairment tied to the insolvency of its German subsidiaries (GMB and Geosphere); stripping that out, underlying PAT still rose roughly 4x (≈₹18.8 Cr adjusted a year ago), so the print is a genuine operating recovery, not just a base-effect optical turnaround. There are no exceptional items this quarter. The recovery sits on margins, not just volume. Consolidated EBITDA margin came in near 31.4%, squarely inside management's guided 30–33% band, driven by firmer domestic realisations and the protection of anti-dumping/safeguard duties on imported solar glass that the company has repeatedly flagged. Revenue of ₹405.7 Cr lands in the middle of management's own ₹400–410 Cr normalised quarterly run-rate guidance from the Q4 concall — so this quarter confirms, rather than contradicts, the confident outlook management gave in May. Exports remain a small slice (₹14.3 Cr, ~4% of revenue), with the business overwhelmingly India-driven (₹391.4 Cr domestic). The headline QoQ moves mislead and should be read with care. Sequentially, revenue fell 7.8% and reported PAT fell 48.8% versus Q4 FY26's ₹169.1 Cr — but that Q4 number was flattered by a ~₹49 Cr tax write-back (PAT exceeded PBT). On a like-for-like PBT basis the two quarters are essentially flat (₹117.9 Cr vs ₹120.1 Cr), meaning underlying profitability held despite a modest topline dip. YoY is the real story here: loss to profit, with margins now normalised. Concurrent with the result, the board's July 16 meeting followed a warrant conversion (94,338 shares allotted for ₹3.75 Cr on July 15, part of the ₹517.7 Cr preferential issue), and the company continues to fund its 60% capacity expansion — ₹50.1 Cr of capex deployed this quarter — expected to contribute from FY28. A GM-HR senior-management exit (July 14) and DSIR R&D recognition (June 25) round out the quarter's corporate developments but are not financially material. No formal quarterly consensus estimate was published for a company of this size; the standalone and consolidated stories are aligned (both ~₹87 Cr PAT), so readers seeing either number are seeing the same result.

Key Highlights

  • Consolidated PAT ₹86.6 Cr vs a ₹203.5 Cr loss a year ago — a turnaround; even adjusted for the prior-year ₹222 Cr exceptional impairment, underlying PAT rose ~4x (from ≈₹18.8 Cr).
  • Revenue ₹405.7 Cr, up 17.1% YoY, down 7.8% QoQ — lands mid-range of management's guided ₹400–410 Cr normalised quarterly run-rate.
  • EBITDA margin ~31.4%, inside the guided 30–33% band; margin expansion (aided by protective duties and firmer domestic realisations) is the core driver, not volume.
  • QoQ PAT drop of 48.8% is optical: Q4 FY26's ₹169.1 Cr was inflated by a ~₹49 Cr tax write-back; on PBT basis Q1 (₹117.9 Cr) is flat vs Q4 (₹120.1 Cr).
  • No exceptional items this quarter; standalone PAT ₹87.7 Cr, broadly matching consolidated — the two bases tell the same story.
  • Warrant conversion (94,338 shares, ₹3.75 Cr) completed July 15; ₹50.1 Cr capex deployed toward the 60% capacity expansion contributing from FY28.
  • EPS ₹6.19 (consolidated, basic, not annualised) vs ₹(12.56) year ago; domestic sales ₹391.4 Cr of ₹405.7 Cr revenue.